GLP-1 RA Use for Obesity Soars Among Nondiabetic US Adults

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Between 2018 and 2022, GLP-1 RA use surged among US adults without diabetes, yet adoption remained modest.
Medscape Medical News